Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response

по Sánchez-Rovira, P., Seguí, M. A., Llombart, A., Aranda, E., Antón, A., Sánchez, A., Lomas, M., Jaén, A., Fernández, M., Porras, I., Dalmau, E., Morales, S., de la Haba-Rodríguez, J.
Опубликовано 2013

Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial

по Alba, E, Albanell, J, de la Haba, J, Barnadas, A, Calvo, L, Sánchez-Rovira, P, Ramos, M, Rojo, F, Burgués, O, Carrasco, E, Caballero, R, Porras, I, Tibau, A, Cámara, M C, Lluch, A
Опубликовано 2014

Preventive treatments for breast cancer: recent developments

по Alés-Martínez, J. E., Ruiz, A., Chacón, J. I., Lluch Hernández, A., Ramos, M., Córdoba, O., Aguirre, E., Barnadas, A., Jara, C., González, S., Plazaola, A., Florián, J., Andrés, R., Sánchez Rovira, P., Frau, A.
Опубликовано в: Clin Transl Oncol (2014)

SEOM–SERAM–SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer

по Fernández-Pérez, G., Sánchez-Escribano, R., García-Vicente, A. M., Luna-Alcalá, A., Ceballos-Viro, J., Delgado-Bolton, R. C., Vilanova-Busquets, J. C., Sánchez-Rovira, P., Fierro-Alanis, M. P., García-Figueiras, R., Alés-Martínez, J. E.
Опубликовано в: Clin Transl Oncol (2017)

Defining the optimal sequence for the systemic treatment of metastatic breast cancer

по Mestres, J. A., iMolins, A. B., Martínez, L. C., López-Muñiz, J. I. C., Gil, E. C., de Juan Ferré, A., del Barco Berrón, S., Pérez, Y. F., Mata, J. G., Palomo, A. G., Gregori, J. G., Pardo, P. G., Mañas, J. J. I., Hernández, A. L., de Dueñas, E. M., Jáñez, N. M., Murillo, S. M., Bofill, J. S., Auñón, P. Z., Sanchez-Rovira, P.
Опубликовано в: Clin Transl Oncol (2016)